Eric Klappholz
Adult Health · Dallas, TXNPI 1003258856
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Viiv Healthcare Company accounts for 74.4% of it on its own, with 27 other manufacturers making up the rest. 2025 is the largest year on record at $23,784, more than ten times the $2,285 reported in 2021. Among adult health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 566 payments — averaging $77.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$33K
- Gilead$6K
- Merck$1K
- Novo Nordisk$698
- EMD Serono, Inc.$470
- Lilly USA, LLC$433
- plus $2K from 22 others
What the payments were for
- Consulting fees$2,1805%
- Speaking & faculty fees$23,25053%
- Travel & lodging$4,56210%
- Food & beverage$13,55831%
- Education$1710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 220 | $32,528 |
| Gilead | 115 | $6,214 |
| Merck | 46 | $1,173 |
| Novo Nordisk | 32 | $698 |
| EMD Serono, Inc. | 27 | $470 |
| Lilly USA, LLC | 17 | $433 |
| Johnson & Johnson(2 entities) | 22 | $394 |
| AbbVie | 12 | $263 |
| Theratechnologies Inc. | 10 | $211 |
| Antares Pharma, Inc. | 13 | $193 |
| Napo Pharmaceuticals Inc | 7 | $175 |
| Otsuka America Pharmaceutical, Inc. | 8 | $153 |
| Janssen Products, LP | 2 | $149 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $129 |
| GSK | 5 | $84 |
| Pfizer | 4 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| AstraZeneca | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Abbott | 2 | $43 |
| Verity Pharmaceuticals Inc. | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Medtronic | 1 | $23 |
| Alkermes, Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,721 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 44 | $207,969 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 15 | $79,725 |
| DovatoDolutegravir Sodium/Lamivudine | 19 | $52,668 |
| DescovyEmtricitabine/Tenofov Alafenam | 19 | $47,085 |
| TivicayDolutegravir Sodium | 17 | $43,826 |
| OzempicSemaglutide | 28 | $30,592 |
| Atorvastatin Calcium | 24 | $286 |
| Acyclovir | 13 | $278 |
| Lisinopril | 17 | $111 |
| Losartan Potassium | 14 | $57 |
| Amlodipine Besylate | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $6,214 | $255,05463 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $32,528 | $96,49436 claims |
| Janssen Products, LPSymtuza | $149 | $79,72515 claims |
| Novo NordiskOzempic | $698 | $30,59228 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 933 adult health providers in Texas.
Other adult health in Dallas
- Melodie YoungDallas$700K
- Megan WheelerDallas$13K
- Joseph SchillDallas$7K
- Misty SheddAllen$863K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.